New in Clinical Trials

Another Alzheimer’s drug candidate suffers setback

17 June 2013 / By Tim / Clinical Trials, Drug Safety, Featured on app / 0 comments

It’s not been a good couple of years for Alzheimer’s research. Recently, Baxter’s Gammagard joined J&J and Pfizer’s iv bapineuzumab and Eli Lilly’s solanezumab in [...]

 

More in Clinical Trials

• 

  Download: A pharma perspective- Assessing challenge and opportunity in expanding clinical development beyond Japan

  17 June 2013 / By jolene / Clinical Trials / 0 comments

   
• 

  Download: Innovation Challenge- Role of Indian Pharma

  14 June 2013 / By jolene / Clinical Trials / 0 comments

   
• 

  eBook: Top 10 Orphan Drug Pipelines in Europe

  13 June 2013 / By Matt Turner / Clinical Trials, Orphan Drugs, Partnering & Investment / 0 comments

   
• 

  The Top 10 Biotech R&D Spenders

  10 June 2013 / By Tim / Clinical Trials, Drug Discovery, Featured on app, Partnering & Investment / 0 comments

   
• 

  Orphan drugs, no longer orphan?

  7 June 2013 / By andre / Clinical Trials, Drug Discovery, Manufacturing, Market Access, Orphan Drugs, Partnering & Investment, Regulation and Government / 0 comments

   
• 

  Download: Optimising Clinical Development & Speeding Patient Access to Orphan Drugs

  5 June 2013 / By Matt Turner / Clinical Trials, Market Access, Orphan Drugs, Partnering & Investment / 0 comments

   
• 

  The 3 PD-1 antibody drugs with huge market potential

  3 June 2013 / By Tim / Antibodies, Clinical Trials, Featured on app / 0 comments

   
• 

  Download: Pharma Trials World India 2013 Conference Programme

  31 May 2013 / By jolene / Clinical Trials / 0 comments

   
• 

  Exclusive Interview with Kevin Huang

  30 May 2013 / By jolene / Clinical Trials, Drug Discovery, Orphan Drugs / 0 comments

   
• 

  Download: Effectively managing clinical trials in emerging companies in Asia- Indonesia

  28 May 2013 / By jolene / Clinical Trials / 0 comments